Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Simvastatin Combination in Hypertension and Hypercholesterolemia
NCT00171093Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valsartan and simvastatin in essential hypertension and hypercholesterolemia (3 arms), sponsored by Novartis. Primary endpoints: Change in average ambulatory systolic blood pressure over 24 hours and Change in serum low density lipoprotein cholesterol. Started Sep 2004; status: completed.
02
Drugs
valsartansimvastatin
03
Conditions
essential hypertensionhypercholesterolemia
Beyond the preview
Go deeper on NCT00171093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171093.